STRATA Skin Sciences, Inc. financial data

Symbol
SSKN on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5 Walnut Grove Drive, Suite 140, Horsham, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
MELA SCIENCES, INC. /NY (to 1/4/2016), ELECTRO OPTICAL SCIENCES INC /NY (to 4/30/2010)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112 % -19.3%
Quick Ratio 19.4 % -51.1%
Debt-to-equity 369 % +87.2%
Return On Equity -121 % -82.4%
Return On Assets -25.9 % -15.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.17M shares -88.1%
Common Stock, Shares, Outstanding 4.17M shares +19%
Entity Public Float 4.96M USD -71.3%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 3.81M shares +9.03%
Weighted Average Number of Shares Outstanding, Diluted 3.81M shares +9.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.6M USD +0.61%
Cost of Revenue 14.5M USD -2.79%
Research and Development Expense 883K USD -33%
Selling and Marketing Expense 12.3M USD -5.15%
General and Administrative Expense 11.3M USD +7.57%
Costs and Expenses 28.3M USD +4.7%
Operating Income (Loss) -9.26M USD -7.57%
Nonoperating Income (Expense) -1M USD +56.8%
Income Tax Expense (Benefit) -170K USD -84.8%
Net Income (Loss) Attributable to Parent -10.1M USD +6.87%
Earnings Per Share, Basic -2.65 USD/shares +14.5%
Earnings Per Share, Diluted -2.65 USD/shares +14.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.26M USD +7.03%
Accounts Receivable, after Allowance for Credit Loss, Current 5.25M USD +18.3%
Inventory, Net 2.25M USD -16%
Assets, Current 16.6M USD +6.77%
Property, Plant and Equipment, Net 10.1M USD -14.6%
Operating Lease, Right-of-Use Asset 1.26M USD +102%
Intangible Assets, Net (Excluding Goodwill) 5.35M USD -26.9%
Goodwill 2.66M USD -59.2%
Other Assets, Noncurrent 231K USD 0%
Assets 36.2M USD -13.9%
Accounts Payable, Current 2.43M USD -27.2%
Employee-related Liabilities, Current 1.78M USD +6.08%
Accrued Liabilities, Current 8.59M USD +36.3%
Contract with Customer, Liability, Current 2.24M USD +5.71%
Liabilities, Current 14.6M USD +20.1%
Contract with Customer, Liability, Noncurrent 300K USD -25%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 919K USD +288%
Liabilities 31.2M USD +6.33%
Retained Earnings (Accumulated Deficit) -248M USD -4.24%
Stockholders' Equity Attributable to Parent 4.97M USD -60.8%
Liabilities and Equity 36.2M USD -13.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -804K USD +1.59%
Net Cash Provided by (Used in) Financing Activities -18K USD
Net Cash Provided by (Used in) Investing Activities -725K USD +59.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 4.17M shares +19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.55M USD +40.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.6M USD +5.88%
Interest Paid, Excluding Capitalized Interest, Operating Activities 480K USD +99.2%
Deferred Tax Assets, Valuation Allowance 51.7M USD +3.06%
Deferred Tax Assets, Gross 52.5M USD +2.49%
Operating Lease, Liability 1.25M USD +112%
Depreciation 3M USD +3.45%
Payments to Acquire Property, Plant, and Equipment 725K USD -59.5%
Lessee, Operating Lease, Liability, to be Paid 1.62M USD +155%
Property, Plant and Equipment, Gross 36.2M USD +0.41%
Operating Lease, Liability, Current 328K USD -6.82%
Lessee, Operating Lease, Liability, to be Paid, Year Two 334K USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 463K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 373K USD +694%
Lessee, Operating Lease, Liability, to be Paid, Year Three 290K USD +48.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 301K USD +447%
Operating Lease, Payments 500K USD +25%
Additional Paid in Capital 253M USD +0.95%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2M USD -25.9%
Depreciation, Depletion and Amortization 4.97M USD -10.5%
Deferred Tax Assets, Net of Valuation Allowance 787K USD -24.8%
Share-based Payment Arrangement, Expense 427K USD -67.2%
Interest Expense 1.88M USD +85.4%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%